ABIVAX Société Anonyme (LON:0RA9)
61.70
-2.20 (-3.44%)
At close: Aug 1, 2025
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$128,370
Profits / Employee
-$2,251,997
Market Cap
4.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 69 | 8 | 13.11% |
Dec 31, 2023 | 61 | 37 | 154.17% |
Dec 31, 2022 | 24 | 0 | - |
Dec 31, 2021 | 24 | -3 | -11.11% |
Dec 31, 2020 | 27 | 1 | 3.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
ABIVAX Société Anonyme News
- 4 days ago - Abivax Announces Closing of $747.5 Million Public Offering - GlobeNewsWire
- 8 days ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing ... - GuruFocus
- 8 days ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) - GlobeNewsWire
- 8 days ago - Abivax: Positive Obefazimod Induction Data Leads To Next 44-Week Maintenance Trial Catalyst - Seeking Alpha
- 9 days ago - Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares - GlobeNewsWire
- 9 days ago - Abivax announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 9 days ago - Abivax launches $400M ADS offering - Seeking Alpha
- 9 days ago - Abivax announces temporary trading halt of its ordinary shares on Euronext Paris - GlobeNewsWire